Birsin Z, Guren AK, Aliyev V, Guliyev M, et al. Capecitabine versus Paclitaxel After CDK4/6 Inhibitor Progression in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Real-World Study. Breast Cancer (Dove Med Press) 2026;18:598598.
PMID: 42011243